TY - JOUR
T1 - Vascular complications in autosomal dominant polycystic kidney disease
AU - Perrone, Ronald D.
AU - Malek, Adel M.
AU - Watnick, Terry
N1 - Publisher Copyright:
© 2015 Macmillan Publishers Limited.
PY - 2015/10/22
Y1 - 2015/10/22
N2 - Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. Relentless cyst growth substantially enlarges both kidneys and culminates in renal failure. Patients with ADPKD also have vascular abnormalities; intracranial aneurysms (IAs) are found in â 1/410% of asymptomatic patients during screening and in up to 25% of those with a family history of IA or subarachnoid haemorrhage. As the genes responsible for ADPKD - PKD1 and PKD2 - have complex integrative roles in mechanotransduction and intracellular calcium signalling, the molecular basis of IA formation might involve focal haemodynamic conditions exacerbated by hypertension and altered flow sensing. IA rupture results in substantial mortality, morbidity and poor long-term outcomes. In this Review, we focus mainly on strategies for screening, diagnosis and treatment of IAs in patients with ADPKD. Other vascular aneurysms and anomalies - including aneurysms of the aorta and coronary arteries, cervicocephalic and thoracic aortic dissections, aortic root dilatation and cerebral dolichoectasia - are less common in this population, and the available data are insufficient to recommend screening strategies. Treatment decisions should be made with expert consultation and be based on a risk-benefit analysis that takes into account aneurysm location and morphology as well as patient age and comorbidities.
AB - Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. Relentless cyst growth substantially enlarges both kidneys and culminates in renal failure. Patients with ADPKD also have vascular abnormalities; intracranial aneurysms (IAs) are found in â 1/410% of asymptomatic patients during screening and in up to 25% of those with a family history of IA or subarachnoid haemorrhage. As the genes responsible for ADPKD - PKD1 and PKD2 - have complex integrative roles in mechanotransduction and intracellular calcium signalling, the molecular basis of IA formation might involve focal haemodynamic conditions exacerbated by hypertension and altered flow sensing. IA rupture results in substantial mortality, morbidity and poor long-term outcomes. In this Review, we focus mainly on strategies for screening, diagnosis and treatment of IAs in patients with ADPKD. Other vascular aneurysms and anomalies - including aneurysms of the aorta and coronary arteries, cervicocephalic and thoracic aortic dissections, aortic root dilatation and cerebral dolichoectasia - are less common in this population, and the available data are insufficient to recommend screening strategies. Treatment decisions should be made with expert consultation and be based on a risk-benefit analysis that takes into account aneurysm location and morphology as well as patient age and comorbidities.
UR - http://www.scopus.com/inward/record.url?scp=84941997170&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941997170&partnerID=8YFLogxK
U2 - 10.1038/nrneph.2015.128
DO - 10.1038/nrneph.2015.128
M3 - Review article
C2 - 26260542
AN - SCOPUS:84941997170
SN - 1759-5061
VL - 11
SP - 589
EP - 598
JO - Nature Reviews Nephrology
JF - Nature Reviews Nephrology
IS - 10
ER -